Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Phase 2 ClinicalTrials
Neuritis; Optic Neuritis Phase 1 ClinicalTrials
Diabetes Mellitus; Diabetes Mellitus, Type 2 Phase 2 ClinicalTrials
Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Sclerosis Phase 2/Phase 3 ClinicalTrials
Polyneuropathies Phase 2/Phase 3 ClinicalTrials
Hypercholesterolemia Phase 2 ClinicalTrials
Adrenoleukodystrophy Phase 2 ClinicalTrials
Multiple Sclerosis; Sclerosis Phase 2 ClinicalTrials
CONTENTS